Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Israel will give fourth COVID-19 shot to people older than 60, health workers
Jan 03, 2022
About 60% of Israel’s 9.4 million people are fully vaccinated with either a recent second dose or booster dose.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.